Biotech China 2014

Pharmacology: National Institutes of Health

Total Score People Score Events Score
24 23 10
Date Event Presentation Speakers
October 17, 2013 14th Annual G Protein-Coupled Receptor (GPCR) Retreat Structure of the agonist-bound neurotensin receptor NTS1 Reinhard Grisshammer
June 4, 2013 World Pharma Congress Organs-on-Chips for Predicting Drug Toxicity and Efficacy Danilo Tagle
April 6, 2013 AACR Annual Meetings BRAF Pathway Inhibitors in Melanoma: Where Do We Go from Here? Chairperson: Richard M. Marais, Paterson Institute for Cancer Research, Manchester, United Kingdom Deborah Morrison
The MICR Scientific Symposium: Why Are Aggressive Forms of Cancer More Common Among Certain Racial/Ethnic Groups? Co-Chairpersons: Christopher I. Li, Fred Hutchinson Cancer Research Center, Seattle, WA, and A. William Blackstock, Wake Forest University School of Medicine, Winston-Salem, NC Curtis C. Harris
Lymphoid Malignancies Co-Chairpersons: Peter J. Campbell, Wellcome Trust Sanger Institute, Cambridge, United Kingdom, and Louis M. Staudt, National Cancer Institute, Bethesda, MD Louis M. Staudt
Novel Therapeutic Concepts with Kinases, Immuno-, and Radiotherapy Chairperson: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY W. Marston Linehan
Predictive Modeling of Cancer Treatment in Single Patients (N of 1) Moderator: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY James H. DOROSHOW
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Louis M. Staudt
Immune Reconstitution Following Lymphodepleting Cancer Therapy: Does It Matter? Crystal L. Mackall, National Cancer Institute, Bethesda, MD Crystal Mackall
February 13, 2011 Inositide Signaling in Pharmacology and Disease (X1) Phosphoinositides in Signaling and Disease | Detection and Rapid Manipulation of Phosphoinositides in Living Cells Tamas Balla
Inositides and Ion Channels | Regulation and Physiological Function of Store-Operated Calcium Entry James W Putney
June 18, 2008 Accelerating Anticancer Agent Development and Validation Workshop Faculty James Doroshow, Giuseppe Giaccone
Panel Discussion Jeffrey S Abrams
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
cancer genetics-- Neurofibromatosis Type 1: The Development and Treatment of Neural Tumors Brigitte C. Widemann
clinical trials-- The End of P Values? Why Alternative Methods to Making Inferences May Be Superior Steven Hirschfeld
developmental therapeutics-- DNA Repair Modulators Yves Pommier
genitourinary cancer-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
lymphoma and plasma cell disorders-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Lois B. Travis
patient and survivor care-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Lois B. Travis
patient and survivor care-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
pediatric cancer-- Neurofibromatosis Type 1: The Development and Treatment of Neural Tumors Brigitte C. Widemann
special sessions-- Opening Ceremony with Presidential Address, NCI Director’s Address, The ASCO Cancer Foundation Donor Appreciation Awards, and Karnofsky Memorial Award Lecture John E. Niederhuber
tumor biology-- Molecular and Pharmacokinetic Aspects of Brain Metastases (M04) Patricia Steeg
meet the professor sessions-- Molecular and Pharmacokinetic Aspects of Brain Metastases (M04) Patricia Steeg
meet the professor sessions-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Lois B. Travis
February 19, 2008 ADMET Europe Quantitative High-Throughput Screening for Cell-Based Toxicity Assays Menghang Xia
December 6, 2007 RAT GENOMICS & MODELS Tumor Biology Toshikazu Ushijima
Workshop on Databases Susan Old
October 11, 2007 Compound Profiling & Chemogenomic Approaches to Drive Decision Making and Predict Clinical Adverse Effects (Oct 11-12) SCREENING AGAINST MULTIPLE TARGETS (Shared Session with Drug Repositioning Summit) (12:30-17:15) Jill Heemskerk
SCREENING AGAINST MULTIPLE TARGETS: Ceftriaxone and Results of Large Scale Screening Efforts (16:15-16:45) Jill Heemskerk
October 10, 2007 Drug Repositioning Summit: Finding New routes to success (Oct 10-11) SCREENING AGAINST MULTIPLE TARGETS (Shared Session with Compound Profiling) (13:30-17:15) Jill Heemskerk
SCREENING AGAINST MULTIPLE TARGETS: Ceftriaxone and Results of Large Scale Screening Efforts (16:15-16:45) Jill Heemskerk
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.